covaxin: DGCI to review applications for full market approval of Covaxin, Covishield today | India News

NEW DELHI: The Drugs Controller General of India (DCGI) headed Subject Expert Committee will review applications of Bharat Biotech and SII for full market approval to Covaxin and Covishield on Friday.
The move comes after the Hyderabad-based Bharat Biotech on Thursday announced that its indigenously developed Covid-19 vaccine Coavaxin is now a universal vaccine for adults and children.
In an application sent to the Drugs Controller General of India (DCGI) this week, V Krishna Mohan, Whole-Time Director at the Hyderabad-based company submitted complete information regarding chemistry, manufacturing and controls, along with pre-clinical and clinical data while seeking regular market authorisation for Covaxin.
Earlier, the manufacturer had claimed that its Covid vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.

Source link